LOGIN  |  REGISTER
Astria Therapeutics

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025

February 26, 2025 | Last Trade: US$95.38 0.18 0.19

WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2025. The cash dividend of $0.24 per share is payable on or about April 30, 2025 to stockholders of record as of the close of business on March 31, 2025.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. 

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

Media

Heather Zoumas-Lubeski
445-248-0577
This email address is being protected from spambots. You need JavaScript enabled to view it.
';document.getElementById('cloaka72ca0a39869960b9fe0563d749fdf62').innerHTML += ''+addy_texta72ca0a39869960b9fe0563d749fdf62+'<\/a>';  

Investors

David DeMartino
646-531-6115
This email address is being protected from spambots. You need JavaScript enabled to view it.
';document.getElementById('cloaked9510a326fdb3ecc8c2ce6776f32b51').innerHTML += ''+addy_texted9510a326fdb3ecc8c2ce6776f32b51+'<\/a>';

 

Zach Weiner
908-591-6955
This email address is being protected from spambots. You need JavaScript enabled to view it.
';document.getElementById('cloak2620ca2216b476194f9ae6e738642c07').innerHTML += ''+addy_text2620ca2216b476194f9ae6e738642c07+'<\/a>';

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page